USD 10.5 billion
Report ID:
SQSG35H2013 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|Tables:
126
|Figures:
77
DNA Sequencing Market size was valued at USD 12.29 Billion in 2023 and is poised to grow from USD 14.39 Billion in 2024 to USD 51.53 Billion by 2032, growing at a CAGR of 17.12% during the forecast period (2025-2032).
The adoption of DNA sequencing for clinical diagnostic purposes is expected to be largely driven by recent technological advancements in Next-Generation and Whole-Genome Sequencing technologies. Advancements in sequencing technology have led the genomics area through a revolution, and sequencing technology has significantly impacted the healthcare industry. An important technological advancement has been brought about by the exponentially increasing sequencing throughput. The sequencing speed has improved dramatically due to the advent of technologies such as NGS by Illumina, as it has made it possible to decipher genetic information at a much faster rate. These systems work on the principle of parallel processing, whereby many DNA segments may be analyzed at the same time. This speed boost triggers a wide spectrum of effects and allows scientists and medical professionals to process huge amounts of genetic data in ways that were practically impossible before.
For instance, Illumina Inc., launched their cloud-based program called Connected Insights in March 2023; it is designed to simplify the tertiary processing of clinical NGS data. In the next few years, these activities are going to advance the growth of the market. However, the interest in personalized medicine and genomic research tends to enhance market growth. DNA sequencing has increasingly become an essential tool for researchers and medical practitioners to obtain crucial information of profound implications on diagnostic and therapeutic approach and prevention of disease as technological breakthroughs continue to unravel the mysteries of the human genome.
US DNA Sequencing Market is poised to grow at a sustainable CAGR for the next forcast year.
Global Market Size
USD 10.5 billion
Largest Segment
Instrument
Fastest Growth
Instrument
Growth Rate
17.12% CAGR
To get more reports on the above market click here to Buy The Report
Global DNA Sequencing Market is segmented by Product & Service, Technology, Workflow, Application, End-use and region. Based on Product & Service, the market is segmented into Consumables, Instruments, Services. Based on Technology, the market is segmented into Sanger Sequencing, Next-Generation Sequencing, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing, Third Generation Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing. Based on Workflow, the market is segmented into Grade. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others. Based on End-use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
DNA Sequencing Market Analysis by Product
In 2023, the consumables segment led the DNA sequencing market, with it showing the highest share by revenue, accounting for 49.12%. This is due to kits and reagents becoming increasingly accessible as they are targeted to the different features of library preparation, including adapter ligation, quality control, and DNA fragmentation. These products are designed to be more intuitive and efficient. These often arrive with preassembled parts and streamlined protocols that decrease the dependence on highly skilled technical staff. Besides this, they are compatible with formalin-fixed tissues and low-input samples that make them suitable for several scientific and therapeutic applications. Provided there is an increase in demand for precise and efficient sequencing solutions, the consumables market will be strong.
The services segment of the DNA sequencing market is expected to grow at the fastest pace in the projection period. This growing requirement is due to the increasing number of firms offering specialized sequencing services specific to diversified research and clinical applications. Major players in this market are GENEWIZ, Illumina, QIAGEN, GenScript, Applied Biological Materials Inc. along with Agilent Technologies, are extending their services to meet the evolving expectations of the researchers and healthcare institutes. The influx of new developments in sequencing technologies puts the entities in a position to bring the best expertise, support and scalable solutions that are expected to further fuel the growth in the services segment and help overcome complex market requirements.
DNA Sequencing Market Analysis by End User
The academic research segment accounted for the largest revenue share of 51.88% in 2023. This is attributed to the large adoption of NGS and Sanger technologies in institutional and academic research programs. Moreover, enhanced financing and investment plans increase the demand for DNA sequencing products and services in these organizations, which boosts their revenue share. In addition, various symposiums, exhibits, and seminars are inspiring scientists and researchers to make use of NGS technology. To increase the yield of diagnosis in newborn care, PacBio and GeneDx just recently partnered with research with the University of Washington in August 2023 for the assessment and knowledge of long-read whole genome sequencing. These are some of the factors that are expected to support market growth in the coming years.
The clinical research segment is expected to grow at the fastest rate during the projection period. NGS methods have become incredibly popular since they can test numerous genes at one time with enormous parallel sequence analysis. Although NGS technologies require less nucleic acids, they are the method of choice for clinical testing procedures due to their potential while evaluating several gene markers. This segment is predicted to grow amazingly due to the employment of DNA analysis in studies regarding tumor heterogeneity, identification of alterations related to carcinogenesis, and new genes related to cancers.
To get detailed analysis on other segments, Request For Free Sample Report
North America currently holds the highest market revenue share at 50.70%. Adoption of DNA sequencing technology is high in this region, with many major players, such as Thermo Fisher Scientific, Inc., Oxford Nanopore Technologies plc, Illumina, Inc., and Agilent Technologies Inc., present in this region. Along with this, the US companies are taking several strategic measures to continue growing their market share in the nation along with that of regional development. For instance, Complete Genomics, Inc., an American company was awarded "Oscars of Innovation" ultra-high throughput gene sequencer, DNBSEQ-T20×2* by R&D World Magazine in August 2023. Innovative product awards and recognitions of this type can be expected to spur new product innovations in the local market.
However, the European DNA sequencing market size is expected to develop at a notable CAGR over the projection period because of rising R&D expenditures and ongoing scientific research that has enhanced the demand for cutting-edge NGS technologies. The UK DNA sequencing market is expected to grow at the highest CAGR during the forecast period due to increased development of companion diagnostics and later molecular diagnostic development facilities by major market players. Further, continued strategic partnerships between players in the European and Eastern markets are expected to drive the expansion of the market in the region during the forecast period. Several government initiatives to promote NGS technologies adoption in the France have been promoting the industry.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
DNA Sequencing Market Driver
Growing Focus on Personalized Therapy
Technological Advancements
Restraints
Costly Infrastructure and Resource Requirements
Difficulties with Data Management
Request Free Customization of this report to help us to meet your business objectives.
Key firms that vie for innovation and market are Illumina, Thermo Fisher Scientific, QIAGEN, and BGI Genomics. Companies invest significantly in R&D to push forward the sequencing technology and provide other services. Common methods by which businesses strengthen their capacities are through mergers & acquisitions and strategic collaborations. Most importantly, the boost of the economy calls for the growth of startups. This brings forth more innovation and strong competition.
DNA Sequencing Market Top Player’s Company Profiles
Recent Developments in DNA Sequencing Industry
Using AI and Machine Learning:
Increasing Interest in Liquid Biopsy Applications:
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the DNA sequencing market is expected to witness rapid growth because of the convergence of technological breakthroughs, growing needs for customized medicine, and the expansion of the application of sequencing in various industries. With such barriers as overpriced costs, complex data management, perpetual breakthroughs in technology, and introduction of artificial intelligence which heighten effectiveness and access. The market is going to witness significant improvement that's going to change health care, research, and diagnostics and eventually end with better patient outcomes and new scientific understanding as the leading companies and new participants continue their development and extension of offerings.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 10.5 billion |
Market size value in 2031 | USD 44 billion |
Growth Rate | 17.12% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the DNA Sequencing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the DNA Sequencing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the DNA Sequencing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the DNA Sequencing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQSG35H2013
sales@skyquestt.com
USA +1 351-333-4748